Abstract:Since, after the successful approval of albumin-based nanodrug "Abraxane" by food and drug administration (FDA) in 2005, considerable interests have been gained by protein-based nanoparticles in the field nanomedicine for cancer therapy. In recent years, various protein-based nanodevices have been developed; amid them, serum albumin as an intrinsic constituent of blood with no immunogenicity and toxicity regarded as an ideal tool to cargo and deliver diagnostic and therapeutic modalities to breast cancer cells simultaneously, named as theranostic. Serum albumin-based nanodevices are commonly loaded or conjugated with near infrared (NIR dyes), contrast agents, radionuclides, photosensitizers and organic or inorganic nanoclusters and chemotherapeutic agents. In general, serum albumin nanodevices offer several advantages such as biocompatibility, biodegradability, prolonged blood circulation, escape clearance by macrophages and surface modification with drugs or targeted ligand. Moreover, it can be easily prepared without using any toxic organic solvent or chemical agents. In addition, the nanoscale size of devices also facilitates the deep penetration into tumor tissue. This mini-review embodies general overview of albumin and its properties, tumor targeting mechanism and designed formulations, along with their applications in breast cancer diagnosis and therapy from the recent literature. Finally, the current challenges and future perspective are identified for translating serum albumin-based nanodevices from laboratory to clinical application. Graphical abstract Download : Download high-res image (218KB) Download : Download full-size image

Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

Application of Albumin in Nanodrugs for Cancer Therapy

Albumin-based drug delivery: harnessing nature to cure disease

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy

Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation

Protein Nanoparticles Directed Cancer Imaging and Therapy

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy

Harnessing albumin as a carrier for cancer therapies

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Inflammation-Targeted Drug Delivery Strategies via Albumin-Based Systems

Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery

Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles

Hyaluronic acid and albumin based nanoparticles for drug delivery

Albumin Nanoparticle Encapsulation of Potent Cytotoxic Therapeutics Shows Sustained Drug Release and Alleviates Cancer Drug Toxicity.

Albumin-based nanodevices for breast cancer diagnosis and therapy

Albumin-binding Prodrugs Via Reversible Iminoboronate Forming Nanoparticles for Cancer Drug Delivery.

Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy

Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications